USCOM (ASX:UCM) Institutional Ownership : 0.30% (As of Jun. 06, 2024)

View and export this data going back to 2003. Start your Free Trial

What is USCOM Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, USCOM's institutional ownership is 0.30%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, USCOM's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, USCOM's Float Percentage Of Total Shares Outstanding is 0.00%.

USCOM Institutional Ownership Historical Data

The historical data trend for USCOM's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

USCOM Institutional Ownership Chart

USCOM Historical Data

The historical data trend for USCOM can be seen below:

	2007-06-30	2007-07-31	2007-08-31	2007-09-30	2007-10-31	2007-11-30	2007-12-31	2008-01-31	2008-02-29	2008-03-31
Institutional Ownership	0.30	0.30	0.30	0.30	0.30	0.30	0.30	0.30	0.30	0.30

USCOM Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

USCOM (ASX:UCM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » USCOM Ltd (ASX:UCM) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

Level 8, 66 Clarence Street, Suite 2, Sydney, NSW, AUS, 2000

Website

https://www.uscom.com.au

USCOM Ltd is engaged in the development, design, manufacture, and marketing of premium non-invasive cardiovascular and pulmonary medical devices. The company's geographical segment includes Australia, Asia, America, Europe, and Other regions. It generates maximum revenue from Australia. The company offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, SPIROSONIC, a pulmonary function testing device based on multi-path ultrasound technology and the VENTITEST and VENTITEST-S ultrasonic ventilator calibration devices for optimizing respiratory device performance.

USCOM (ASX:UCM) Headlines

No Headlines